Follow-on Biologics

Follow-on Biologics

Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, First Session, on Examining Food and Drug Administration Follow-on Biologics, Generally Referred to as A Biotechnology-derived Protein Drug (or Biologic) That Is Comparable to A Novel, Previously Approved Biologic and That Is Approved With Less Supporting Data Than the Innovator Biologic, March 8, 2007

Book - 2008
Rate this:
Publisher: Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008
ISBN: 9780160817557
Branch Call Number: 615.190973 U58 HF
Characteristics: iv, 78 p. ;,24 cm


From the critics

Community Activity


Add a Comment

There are no comments for this title yet.


Add Age Suitability

There are no ages for this title yet.


Add a Summary

There are no summaries for this title yet.


Add Notices

There are no notices for this title yet.


Add a Quote

There are no quotes for this title yet.

Explore Further


Subject Headings


Find it at BPL

To Top